301 related articles for article (PubMed ID: 27505270)
1. Clinical and Molecular Characteristics of Neonatal Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacteremia: A 12-Year Case-Control-Control Study of a Referral Center in Taiwan.
Tsai MH; Lee IT; Chu SM; Lien R; Huang HR; Chiang MC; Fu RH; Hsu JF; Huang YC
PLoS One; 2016; 11(8):e0159744. PubMed ID: 27505270
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU.
Tsai MH; Chu SM; Hsu JF; Lien R; Huang HR; Chiang MC; Fu RH; Lee CW; Huang YC
Pediatrics; 2014 Feb; 133(2):e322-9. PubMed ID: 24420803
[TBL] [Abstract][Full Text] [Related]
3. Neonatal gram-negative bacillary late-onset sepsis: A case-control-control study on a prospectively collected database of 5,233 admissions.
Tsai MH; Wu IH; Lee CW; Chu SM; Lien R; Huang HR; Chiang MC; Fu RH; Hsu JF; Huang YC
Am J Infect Control; 2016 Feb; 44(2):146-53. PubMed ID: 26559734
[TBL] [Abstract][Full Text] [Related]
4. Extended-spectrum beta lactamase-producing gram-negative bacteria: clinical profile and outcome in a neonatal intensive care unit.
Sehgal R; Gaind R; Chellani H; Agarwal P
Ann Trop Paediatr; 2007 Mar; 27(1):45-54. PubMed ID: 17469732
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003.
Chayakulkeeree M; Junsriwong P; Keerasuntonpong A; Tribuddharat C; Thamlikitkul V
Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1503-9. PubMed ID: 16610653
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance and extended-spectrum beta-lactamase producing Gram-negative bacteria from three Referral Hospitals of Amhara region, Ethiopia.
Moges F; Gizachew M; Dagnew M; Amare A; Sharew B; Eshetie S; Abebe W; Million Y; Feleke T; Tiruneh M
Ann Clin Microbiol Antimicrob; 2021 Mar; 20(1):16. PubMed ID: 33706775
[TBL] [Abstract][Full Text] [Related]
7. Rectal screening displays high negative predictive value for bloodstream infection with (ESBL-producing) Gram-negative bacteria in neonates with suspected sepsis in a low-resource setting neonatal care unit.
Lenglet A; Schuurmans J; Ariti C; Borgundvaag E; Charles K; Badjo C; Clezy K; Evens E; Senat-Delva R; Berthet M; Lekkerkerker M; McRae M; Wertheim H; Hopman J
J Glob Antimicrob Resist; 2020 Dec; 23():102-107. PubMed ID: 32890840
[TBL] [Abstract][Full Text] [Related]
8. β LACTA test performance for detection of extended-spectrum β-lactamase-producing Gram-negative bacilli directly on bronchial aspirates samples: a validation study.
Gallah S; Benzerara Y; Tankovic J; Woerther PL; Bensekri H; Mainardi JL; Arlet G; Vimont S; Garnier M
Clin Microbiol Infect; 2018 Apr; 24(4):402-408. PubMed ID: 28782646
[TBL] [Abstract][Full Text] [Related]
9. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital.
Osthoff M; McGuinness SL; Wagen AZ; Eisen DP
Int J Infect Dis; 2015 May; 34():79-83. PubMed ID: 25769526
[TBL] [Abstract][Full Text] [Related]
10. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
Massart N; Camus C; Benezit F; Moriconi M; Fillatre P; Le Tulzo Y
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):889-895. PubMed ID: 31898797
[TBL] [Abstract][Full Text] [Related]
12. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
[TBL] [Abstract][Full Text] [Related]
14. Restriction of cephalosporins and control of extended spectrum beta-lactamase producing gram negative bacteria in a neonatal intensive care unit.
Murki S; Jonnala S; Mohammed F; Reddy A
Indian Pediatr; 2010 Sep; 47(9):785-8. PubMed ID: 21048261
[TBL] [Abstract][Full Text] [Related]
15. Extended-spectrum beta-lactamase-producing Gram-negative bacteria causing neonatal sepsis in India in rural and urban settings.
Chandel DS; Johnson JA; Chaudhry R; Sharma N; Shinkre N; Parida S; Misra PR; Panigrahi P
J Med Microbiol; 2011 Apr; 60(Pt 4):500-507. PubMed ID: 21183602
[TBL] [Abstract][Full Text] [Related]
16. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
17. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
[TBL] [Abstract][Full Text] [Related]
18. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
Gudiol C; Calatayud L; Garcia-Vidal C; Lora-Tamayo J; Cisnal M; Duarte R; Arnan M; Marin M; Carratalà J; Gudiol F
J Antimicrob Chemother; 2010 Feb; 65(2):333-41. PubMed ID: 19959544
[TBL] [Abstract][Full Text] [Related]
19. Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia.
Palmer HR; Palavecino EL; Johnson JW; Ohl CA; Williamson JC
Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):955-9. PubMed ID: 23397233
[TBL] [Abstract][Full Text] [Related]
20. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study.
Tacconelli E; Górska A; De Angelis G; Lammens C; Restuccia G; Schrenzel J; Huson DH; Carević B; Preoţescu L; Carmeli Y; Kazma M; Spanu T; Carrara E; Malhotra-Kumar S; Gladstone BP
Clin Microbiol Infect; 2020 Jan; 26(1):87-94. PubMed ID: 31128285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
